NIH-funded research R01 grant

How exposure to a common flame retardant affects metabolism differently in men and women

Official title: Mechanisms of Sex-specific Metabolic Disruption Caused by Organophosphate Flame Retardant Exposure

Funded at University of Kentucky · NIH-10979373 · Data updated 2026-11-12

This study looks at how a common flame retardant called TDCPP might affect metabolism and health, especially in men, by testing it on mice to see how it influences body fat and insulin resistance, which could help us understand its effects on people and guide health advice.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startJuly 1, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$429,135
NIH project number1R01ES034786-01A1
Project IDNIH-10979373 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adult males who may be affected by metabolic syndrome or related conditions.

Less likely to help

Patients who are not male or do not have metabolic health concerns may not benefit from this research.

What this research studies

This research investigates how exposure to the flame retardant TDCPP affects metabolic health, particularly focusing on differences between sexes. The study uses a mouse model to simulate human exposure and examines how TDCPP impacts body fat and insulin resistance, especially in male mice. By analyzing the metabolic changes and the mechanisms involved, the research aims to understand the broader implications of this chemical on human health. The findings could help identify at-risk populations and inform public health recommendations.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and management of metabolic disorders linked to environmental exposures.

How similar studies have gone: Previous studies have shown associations between environmental chemicals and metabolic disorders, suggesting that this research could build on established findings.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Rashid, Cetewayo Saif — University of Kentucky
  • Study coordinator: Rashid, Cetewayo Saif

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.